2-Anilino-4-(imidazol-5-yl)-pyrimidine derivatives and their use as cdk (cdk2) inhibitors
申请人:AstraZeneca AB
公开号:US07427626B2
公开(公告)日:2008-09-23
Compounds of the formula (I), and pharmaceutically acceptable salts and in vivo hydrolysable esters thereof are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti cell proliferation) effect in a warm blooded animal, such as man.
本文描述了化学式(I)的化合物,以及其药学上可接受的盐和体内可水解的酯。还描述了它们的制备过程以及它们作为药物的用途,特别是作为产生细胞周期抑制(抗细胞增殖)作用的药物,用于温血动物,如人类。